Press releases
- Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
- Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
- ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
- Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
- Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Personalis Reports First Quarter 2024 Financial Results
- Personalis to Announce First Quarter 2024 Financial Results
More ▼
Key statistics
As of last trade, Personalis Inc (04X:DUS) traded at 1.16, 41.19% above the 52 week low of 0.823 set on Nov 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.16 |
---|---|
High | 1.20 |
Low | 1.16 |
Bid | 1.16 |
Offer | 1.19 |
Previous close | 1.22 |
Average volume | 0.00 |
---|---|
Shares outstanding | 51.94m |
Free float | 51.52m |
P/E (TTM) | -- |
Market cap | 61.81m USD |
EPS (TTM) | -1.89 USD |
Data delayed at least 15 minutes, as of Jul 04 2024 15:30 BST.
More ▼